The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
We are pleased to present below all posts archived in 'August, 2017'. If you still can't find what you are looking for, try using the search box.
Construction work at the £24m Park Drive East development at Milton Park being undertaken by MEPC has reached the half way milestone
Read the rest of entry »
Novartis AG won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment that marks the start of a potential new treatment paradigm for some cancers.
Gilead Sciences is buying Kite Pharma in a deal worth $11.9 billion, securing itself access to the latter’s experimental CAR-T therapy axicabtagene ciloleucel and wider cancer pipeline.
The Midlands Engine Investment Fund aims to boost the region’s economy and supporting the growth ambitions of the 780,000 smaller businesses within the region. It is part funded by the European Regional Development Fund.
Professor Sir John Bell, who led a review into the £64 billion life sciences industry, will use a speech at the University of Birmingham's Institute of Translational Medicine on Wednesday to outline its findings.
AMSBIO announces its sponsorship of the 'Discovering Organoids: Establishment, Culture & Manipulation’ hands-on training course* due to be hosted at Homerton College, University of Cambridge, UK, on 11th and 12th September 2017.
Merck Ventures Joins Investment Syndicate and the Board of Macrophage
Oxford Immunotec intends to use the net proceeds from the offering for working capital and general corporate purposes.
The Department for International Trade Life Sciences Organisation (DIT LSO) and the China Britain Business Council (CBBC) will be hosting a delegation from the Future Health Industry Entrepreneurs Association (FHA) from China on the morning of Tue 5 Sep.
AMSBIO announces the launch of a new Hyaluronic Acid Quantification Kit, based on a highly specific and tightly binding protein to detect and measure Hyaluronic Acid, also known as Hyaluronan or HA.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, email@example.com, and we will post.